Hospira

Hospira-Danone Tax Inversion Deal Stalls
Tax

Hospira-Danone Tax Inversion Deal Stalls

The $5 billion cross-border deal involving the French company's medical nutrition business is apparently on hold.
By Iris Dorbian | September 4, 2014
Read More
Another Tax Inversion Deal in the Works
Tax

Another Tax Inversion Deal in the Works

The hue and cry over tax inversions is not stopping companies from proceeding with more mergers that take advantage of the tactic.
By Iris Dorbian | July 28, 2014
Read More